Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals Income Statement

Financials in millions ILS. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Selling, General & Admin	6.07	6.58	4.5	1.43	1.51	4.86	3.99	2.46	1.3	0.77	Upgrade
Research & Development	3.31	2.67	1.56	0.24	0.05	4.17	3.55	2.55	1.82	0.94	Upgrade
Other Operating Expenses	0	0	0	0	0	0	0	-0.09	-0	0	Upgrade
Operating Expenses	9.38	9.26	6.06	1.67	1.56	9.03	7.54	4.92	3.12	1.71	Upgrade
Operating Income	-9.38	-9.26	-6.06	-1.67	-1.56	-9.03	-7.54	-4.92	-3.12	-1.71	Upgrade
Interest Expense / Income	0	0.71	1.37	0.05	0	0.01	1.2	0.01	0.02	0.01	Upgrade
Other Expense / Income	-0.69	-0.59	14.03	0.38	-	-2.83	-0.03	-0.2	-0	-0.01	Upgrade
Pretax Income	-8.69	-9.38	-21.46	-2.1	-1.56	-6.21	-8.71	-4.73	-3.14	-1.71	Upgrade
Net Income	-8.69	-9.38	-21.46	-2.1	-1.56	-6.21	-8.71	-4.73	-3.14	-1.71	Upgrade
Shares Outstanding (Basic)	1	0	26	20	20	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	-	-	26	20	20	0	0	0	0	0	Upgrade
Shares Change	144.43%	-98.47%	31.42%	-	928242.65%	15.59%	22.84%	22.40%	12.92%	34.19%	Upgrade
EPS (Basic)	-	-	-600.00	-41999.99	-31199.99	-2870.35	-4666.64	-3111.09	-2537.02	-1555.55	Upgrade
EPS (Diluted)	-	-	-600.00	-41999.99	-31199.99	-2870.35	-4666.64	-3111.09	-2537.02	-1555.55	Upgrade
Free Cash Flow	-7.86	-8.73	-6.35	-1.46	-1.3	-7.5	-5.57	-4.81	-2.46	-1.43	Upgrade
Free Cash Flow Per Share	-7.97	-21.62	-0.24	-0.07	-0.07	-3475.58	-2982.96	-3166.45	-1980.52	-1299.15	Upgrade
EBITDA	-8.58	-8.56	-19.99	-1.94	-1.54	-6.06	-7.4	-4.61	-3.09	-1.69	Upgrade
Depreciation & Amortization	0.1	0.1	0.1	0.1	0.02	0.14	0.11	0.11	0.02	0.01	Upgrade
EBIT	-8.69	-8.67	-20.1	-2.05	-1.56	-6.2	-7.51	-4.72	-3.12	-1.7	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).